-
Real-world study of oral cladribine for Brazilian patients with multiple sclerosis: results from the BRANDO Registry
-307742 -
Evaluation of neuromyelitis optica spectrum disorder in patients under Rituximab and applicability of no responsiveness criteria for first-line therapies: A real-world data in resources limited settings
-307749 -
REHABILITATION ACCESS PROFILE OF PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS IN REFERENCE CENTER AT NORTHEAST BRAZIL
-307752 -
The effect of total dietary antioxidant capacity (TDAC) in clinical and nutritional status in people with neuromyelitis optica spectrum disorder
-307782 -
Correlations between Multiple Sclerosis, Cognition, Human Development Index, and Social Vulnerability.
-307794
Publications in other proceedings
-
BCTRIMS 2023
Recurrent drug-induced hepatitis associated with corticosteroids in a patient with multiple sclerosis
-
BCTRIMS 2023
Parkinsonism as rare manifestation of acute multiple sclerosis
-
BCTRIMS 2023
Cognitive Decline as Early Manifestation of Multiple Sclerosis: A Case Series
-
BCTRIMS 2023
Neuromyelitis Optica Association in Identical Twins: A Case Report and Review of Literature
-
BCTRIMS 2023
Natalizumab treatment in relapsing-remitting multiple sclerosis: a thirteen-year experience in a low prevalence and mixed-race population MS center.
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
